What are the causes and management of hyperferritinemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Causes and Management of Hyperferritinemia

The most common causes of hyperferritinemia include chronic alcohol consumption, inflammation, cell necrosis, tumors, and non-alcoholic fatty liver disease (NAFLD)/metabolic syndrome, which account for over 90% of outpatient cases. 1

Primary Causes of Hyperferritinemia

  • Iron Overload Disorders:

    • Hereditary hemochromatosis (HFE gene mutations - C282Y homozygosity, C282Y/H63D compound heterozygosity) 2, 1
    • Non-HFE hemochromatosis (mutations in TFR2, SLC40A1, HAMP, HJV genes) 1, 3
    • Ferroportin disease (autosomal dominant condition with iron overload) 4
  • Genetic Disorders Without Iron Overload:

    • Hyperferritinemia-cataract syndrome 5

Secondary Causes of Hyperferritinemia

  • Inflammatory Conditions:

    • Systemic inflammatory response syndrome 1
    • Adult-onset Still's disease (AOSD) 1
    • Rheumatic conditions 3
    • Chronic inflammatory disorders 6
  • Liver Diseases:

    • Alcoholic liver disease 1
    • Non-alcoholic fatty liver disease (NAFLD) 1, 7
    • Viral hepatitis (B and C) 1
    • Acute hepatitis 1
    • Chronic liver disease 3
  • Hematologic Disorders:

    • Hemolytic anemia 6
    • Thalassemia syndromes 3
    • Myelodysplastic syndrome 3
    • Myelofibrosis 3
    • Sideroblastic anemias 3
    • Sickle cell disease 3
    • Chronic transfusion 8
  • Other Causes:

    • Malignancies (solid tumors and lymphomas) 1, 3, 8
    • Infections 1, 3
    • Metabolic syndrome 1, 7
    • Cell necrosis 1
    • Kidney failure 3
    • Hemophagocytic lymphohistiocytosis (HLH) 8

Diagnostic Approach to Hyperferritinemia

  1. Initial Assessment:

    • Measure serum ferritin and transferrin saturation (TS) 1, 4
    • Check inflammatory markers (CRP, ESR) 4
    • Assess liver function tests 4
  2. Interpretation of Initial Results:

    • TS <20% with ferritin >100 μg/L suggests anemia of chronic disease 4
    • TS ≥45% with elevated ferritin suggests potential iron overload 2
    • Normal TS with elevated ferritin suggests inflammation, liver disease, or other non-iron overload causes 6
  3. Further Evaluation Based on Initial Results:

    • If TS ≥45% (suggesting iron overload):

      • Perform HFE genetic testing for C282Y and H63D mutations 2, 3
      • If C282Y homozygous: diagnosis of HFE-related hemochromatosis 2
      • If other genotypes or negative: consider secondary causes or non-HFE hemochromatosis 2, 5
    • If TS <45% (suggesting non-iron overload causes):

      • Evaluate for inflammation (check CRP) 2, 1
      • Assess for cell necrosis (check AST, ALT, CK) 2, 1
      • Screen for metabolic syndrome (check blood pressure, BMI, cholesterol, triglycerides, glucose) 2, 7
      • Consider malignancy evaluation (ESR, imaging) 1
  4. Advanced Testing When Indicated:

    • Liver biopsy for hepatic iron concentration and histopathology in unclear cases 2
    • MRI for non-invasive assessment of hepatic iron 1, 5
    • Testing for non-HFE hemochromatosis genes (TFR2, SLC40A1, HAMP, HJV) when iron overload is confirmed but HFE testing is negative 2, 1
    • Glycosylated ferritin measurement (≤20% suggests adult-onset Still's disease) 1

Management of Hyperferritinemia

  1. Treatment of Underlying Cause:

    • Address primary etiology (inflammation, liver disease, etc.) 4
  2. Management of Iron Overload:

    • Hereditary Hemochromatosis:

      • Therapeutic phlebotomy is the mainstay of treatment 2
      • Target serum ferritin <500 μg/L to prevent toxicity 4
    • Secondary Iron Overload:

      • Iron chelation therapy with:
        • Deferiprone: oral iron chelator for transfusional iron overload 9
        • Deferoxamine: for acute iron intoxication and chronic transfusional iron overload 10
      • Monitor for adverse effects of chelation therapy:
        • Auditory and ocular toxicity 10
        • Renal toxicity 10
        • Respiratory distress 10
        • Growth suppression in pediatric patients 10
        • Serious infections (mucormycosis, Yersinia) 10
    • NAFLD with Hyperferritinemia:

      • Lifestyle modifications are more effective than phlebotomy when hyperferritinemia is due to inflammation rather than iron overload 7
      • Phlebotomy is only effective with hepatocellular iron overload 7
  3. Monitoring:

    • Regular assessment of serum ferritin and transferrin saturation 2
    • Liver function tests 2
    • Specific monitoring based on underlying cause 1

Important Clinical Pearls

  • Serum ferritin <1000 μg/L has high negative predictive value for cirrhosis in hemochromatosis patients 2, 1
  • Serum ferritin >1000 μg/L with elevated liver enzymes and platelet count <200 predicts cirrhosis in 80% of C282Y homozygotes 1
  • In the general population, iron overload is not the most common cause of elevated ferritin 2
  • Extreme hyperferritinemia (>10,000 ng/mL) is most commonly due to chronic transfusion (35%), liver disease (27%), and hematologic malignancy (16%) 8
  • When using Vitamin C with iron chelation therapy, limit to 200 mg daily to avoid cardiac dysfunction 9, 10

References

Guideline

Hyperferritinemia Causes and Diagnosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Iron overload disorders.

Hepatology communications, 2022

Guideline

Elevated Ferritin and Folate: Diagnostic Approach and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

[How to interpret a hyperferritinemia?].

Revue medicale de Bruxelles, 2007

Research

Extreme Hyperferritinemia:  Causes and Impact on Diagnostic Reasoning.

American journal of clinical pathology, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.